accountalso receive a double-digit percentage royalty. Approval in Europe triggers a $25 million milestone payment to Acorda. Separately, Merck & Co's new hepatitis C drug Victrelis was recommended for approval in Europe today, just one week after being...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Regulators reverse Fampyra decision
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account